FGF23 and chronic kidney disease: Indeed, FGF-23 drives macrophage proliferation via FGF receptor-1c and instigates tumor necrosis factor (TNF)-α generation in-vitro, linking bone remodeling to myeloid cell inflammation in CKD [67, 84].